SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-023631
Filing Date
2021-05-05
Accepted
2021-05-05 07:21:16
Documents
103
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20210331.htm   iXBRL 10-Q 3748718
2 EX-4.5 ex45.htm EX-4.5 13032
3 EX-10.5 ex105.htm EX-10.5 86040
4 EX-31.1 hznp-ex311_871.htm EX-31.1 16076
5 EX-31.2 hznp-ex312_872.htm EX-31.2 15829
6 EX-32.1 hznp-ex321_869.htm EX-32.1 8962
7 EX-32.2 hznp-ex322_870.htm EX-32.2 8983
  Complete submission text file 0001564590-21-023631.txt   14425849

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hznp-20210331.xsd EX-101.SCH 97573
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20210331_cal.xml EX-101.CAL 87473
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20210331_def.xml EX-101.DEF 370626
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20210331_lab.xml EX-101.LAB 678181
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20210331_pre.xml EX-101.PRE 584783
13 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20210331_htm.xml XML 2826496
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 21891158
SIC: 2834 Pharmaceutical Preparations